A clinical reference for physicians, longevity directors, GLP-1 prescribers and specifiers placing ARX into client environments. Compiled from 13 peer-reviewed studies. Independent — not a promotional document.
Primary study
n=45 RCT
Dalleck 2021
Replications
12 supporting
2022–2026
Indications
7 clinical
Detailed below
Last review
Mar 2026
Independent
Dalleck LC, et al. (2021). ARX vs. traditional resistance training. International Journal of Research in Exercise Physiology. Validation commentary published by American Council on Exercise.
ARX
Traditional
Difference
Body fat
−5.1 %
−2.0 %
2.5× greater
Lean mass
+1.7 kg
+0.8 kg
2× greater
VO₂max
+3.0 ml/kg/min
+0.9 ml/kg/min
3.5× greater
Strength · 1-RM
+38 %
+20 %
90 % greater
Session time
15 min avg
45 min avg
72 % less time
Ratio figures from Dalleck et al., 2021. Individual group data approximated from published analysis.
Randomized controlled design. n=45. 12-week intervention. Three comparative arms. Untrained adults aged 18–65.
Single-site RCT with modest sample size. Comparison group trained at moderate intensity per ACSM guidelines. Replication is needed. This remains the only published comparative trial for any adaptive resistance technology.
Filter by topic. Click any citation to copy a fully-formed reference to your clipboard.
2021
Exercise dosing[1]Comparative trial reported superior changes in body composition, strength and VO2max with substantially lower time demand.
Dalleck LC, et al. (2021). ARX vs. traditional resistance training RCT. International Journal of Research in Exercise Physiology; validated by ACE.
2022
Mortality[2]Meta-analytic evidence supports resistance training as an independent mortality-risk reduction strategy.
Saeidifard F, et al. (2022). Resistance training and all-cause/CVD/cancer mortality. American Journal of Preventive Medicine.
2023
Eccentric[3]Motorized systems are discussed as controlled, precise pathways for delivering eccentric-focused stimuli.
Nuzzo JL, et al. (2023). CARE framework for resistance exercise methods. PubMed Central PMC10127187.
2024
Eccentric[4]Demonstrated efficacy across sexes with continued adaptation over repeated sessions.
Galiano C, et al. (2024). Accentuated eccentric loading responses in men and women.
2024
Exercise dosing[5]Low weekly training time produced measurable improvements in power, strength and hypertrophy metrics.
Scientific Reports (Nature) (2024). Once-weekly eccentric training outcomes.
2024
Mortality[6]Higher strength percentile remained associated with lower mortality among adults aged 90+.
Landi F, et al. (2024). Strength and mortality in the oldest-old. Journal of Cachexia, Sarcopenia and Muscle.
2025
Eccentric[7]Expert consensus favored controlled eccentric tempo and clustered prescriptions for adaptation quality.
Handford C, et al. (2025). Delphi consensus on eccentric resistance programming.
2025
Eccentric[8]Pooled analysis showed stronger strength effects favoring eccentric-focused strategies in older cohorts.
Chaabène H, et al. (2025). Eccentric vs traditional resistance in older adults (11 RCTs).
2025
Mortality[9]Muscle power metrics outperformed isolated strength values in mortality-risk discrimination.
Lopes J, et al. (2025). Muscle power as mortality predictor. Mayo Clinic Proceedings.
2025
Bone density[10]High-intensity resistance protocols improved clinically relevant BMD outcomes at spine and hip regions.
Frontiers in Physiology (2025). Resistance exercise effects on bone mineral density.
2025
GLP-1[11]GLP-1 associated weight reduction may include substantial lean-mass loss, reinforcing resistance-training referral pathways.
STEP-1/SURMOUNT follow-up analyses; ACE and ENDO reports (2025).
2026
Eccentric[12]Review-level synthesis supports superior adaptations in strength/power/hypertrophy ranges under eccentric overload conditions.
Zhong R, et al. (2026). Review of accentuated eccentric loading outcomes.
2026
Mortality[13]Higher strength strata were associated with materially lower mortality risk independent of aerobic participation.
JAMA Network Open (2026). Muscle strength and all-cause mortality in 5,472 women.
Progressive resistance is foundational. Eccentric-focused protocols may support stronger adaptation in aging populations. Evidence from older-adult and oldest-old cohorts supports strength as a meaningful health marker.
High-intensity resistance interventions are associated with improved BMD outcomes at clinically important regions — spine and hip — supporting inclusion in osteopenia and osteoporosis risk-reduction plans.
GLP-1 treatment pathways increasingly require formal resistance-training referral due to lean-mass loss. Structured strength work complements medical obesity management.
With clearance and proper progression, controlled load environments improve reproducibility and session documentation in plans where dosing consistency is critical.
Comparative data suggest clinically relevant cardiorespiratory responses can occur alongside strength gains, especially in deconditioned populations.
Objective force and power metrics assist decision-making in return-to-sport progression by supplementing traditional clinical testing with measurable output trends.
Studies are added when they appear in indexed peer-reviewed venues or in Delphi-style consensus reports from clinical bodies. ARX does not author the studies. Where a finding implicates ARX equipment specifically, the citation is flagged. Where a finding implicates the broader resistance-training literature, the citation is included for completeness.
For clinical inquiries — Kyle Chance, ARX Clinical Partnerships. kyle@arxfit.com. Specifier inquiries route to the same desk. This document is not a product claim. ARX does not represent that any individual outcome will match the trial averages above.